No needle required

Medical innovations have brought new and improved treatments to patients across the globe. For example, while diabetes treatment often involves painful injections, new research shows that needle-free injection is a viable therapy for diabetes and effective blood glucose control.
Makrolon® Rrx1805 polycarbonate is used in needle-free injectors for easier, less painful diabetic treatment. Photo: QS Medical Technology Co., Ltd.

Now, more than 114 million Chinese patients can benefit from a highly effective and potentially more comfortable treatment through a needle-free injection technology from QS Medical Technology Co., LTD (QS).

These high-quality, needle-free injectors utilize Makrolon® Rx1805 polycarbonate. This medical-grade material offers durability, processability and design flexibility to the insulin-delivery interface and medicine ampoules. It ensures that the drug-delivery component can consistently puncture through the plug of an insulin ampoule, and also allows for the drug-sampling needle and the protective cover of the drug suction apparatus to be injection molded in one shot.

Other benefits of Makrolon® Rx1805 polycarbonate include:

  • Resistant to cracking against lipids and radiation sterilization
  • Ability to ensure high productivity and efficiency during the molding of the ampoule bottles, and maintain stability under different application environments
  • Biocompatible and complies with multiple requirements of ISO 10993
  • High impact resistance
  • Accuracy in molding size
  • This innovative needle-free technology makes life easier and more comfortable for millions of diabetes patients in China and around the world — no needle required.

    For more information, email us: plastics@covestro.com.

    Makrolon® is a registered trademark of the Covestro group.

    « Back to Overview